224 results on '"Sujoy Pal"'
Search Results
2. C1QA and COMP: plasma-based biomarkers for early diagnosis of pancreatic neuroendocrine tumors
- Author
-
Priya Kumari Gorai, Prahalad Singh Bharti, Shashi Kumar, Girish H. Rajacharya, Sabyasachi Bandyopadhyay, Sujoy Pal, Renu Dhingra, Rakesh Kumar, Fredrik Nikolajeff, Saroj Kumar, and Neerja Rani
- Subjects
Medicine ,Science - Abstract
Abstract Pancreatic Neuroendocrine tumors (PanNET) are challenging to diagnose and often detected at advanced stages due to a lack of specific and sensitive biomarkers. This study utilized proteomics as a valuable approach for cancer biomarker discovery; therefore, mass spectrometry-based proteomic profiling was conducted on plasma samples from 12 subjects (3 controls; 5 Grade I, 4 Grade II PanNET patients) to identify potential proteins capable of effectively distinguishing PanNET from healthy controls. Data are available via ProteomeXchange with the identifier PXD045045. 13.2% of proteins were uniquely identified in PanNET, while 60% were commonly expressed in PanNET and controls. 17 proteins exhibiting significant differential expression between PanNET and controls were identified with downstream analysis. Further, 5 proteins (C1QA, COMP, HSP90B1, ITGA2B, and FN1) were selected by pathway analysis and were validated using Western blot analysis. Significant downregulation of C1QA (p = 0.001: within groups, 0.03: control vs. grade I, 0.0013: grade I vs. grade II) and COMP (p = 0.011: within groups, 0.019: control vs grade I) were observed in PanNET Grade I & II than in controls. Subsequently, ELISA on 38 samples revealed significant downregulation of C1QA and COMP with increasing disease severity. This study shows the potential of C1QA and COMP in the early detection of PanNET, highlighting their role in the search for early-stage (Grade-I and Grade-II) diagnostic markers and therapeutic targets for PanNET.
- Published
- 2023
- Full Text
- View/download PDF
3. CT-Guided Transhepatic Catheter Drainage of Deep Postoperative Collections: Initial Experience
- Author
-
Akhil Baby, Danny Joy, Nihar R. Dash, Sujoy Pal, Deep N. Srivastava, and Kumble S. Madhusudhan
- Subjects
postop collection drainage ,interventional radiology ,computed tomography guided drainage ,Medical physics. Medical radiology. Nuclear medicine ,R895-920 - Abstract
Purpose This article assesses the safety and utility of transhepatic drainage of deep seated postoperative intra-abdominal collections under computed tomography (CT) guidance in a short series. Methods This retrospective study included five patients (mean age: 45.8 years; 3 males, 2 females) who underwent CT-guided transhepatic drainage of postoperative abdominal abscess in our department between April 2019 and December 2020. The clinical and surgical details and the details of the transhepatic drainage procedure were evaluated along with success rates and complications. Results The surgical procedures were Whipple's pancreaticoduodenectomy in four patients and gastrectomy in one patient. Four out of five abscesses were drained through the right lobe of liver, while one was through the left lobe with a technical success rate of 100%. The mean total time for catheter drainage procedure including patient positioning and preparation was 29.2 minutes. None of the patients had procedure-related complications. Mean duration of catheter drainage was 12 days. All patients had complete resolution of symptoms after drainage and the clinical success rate was 100%. Conclusion Transhepatic approach is safe and effective for the drainage of inaccessible postoperative abdominal collections or abscesses where a standard percutaneous approach is not possible.
- Published
- 2022
- Full Text
- View/download PDF
4. NOTTO guidelines for vaccine-induced thrombotic thrombocytopenia in organ donation and transplantation
- Author
-
Vivek B Kute, Sonal Asthana, Subhash Gupta, Sanjay K Agarwal, Swarnalatha Guditi, Manisha Sahay, Sujoy Pal, S Sudhindran, Ashish Sharma, Sandeep Seth, Alla Gopala Krishna Gokhale, Milind Dhahir Hote, Arpita Ray Chaudhury, Arvinder Singh Soin, Mohamed Rela, Rajesh Malhotra, Virinder K Bansal, Devinder Singh Rana, Rajneesh Sahai, and Vasanthi Ramesh
- Subjects
covid-19 ,deceased donor ,national organ and tissue transplant organization ,organ donation ,transplantation ,vaccine-induced thrombotic thrombocytopenia ,Surgery ,RD1-811 - Abstract
From the context of organ donation, COVID-19 vaccine-induced thrombotic thrombocytopenia (VITT) is important as there is an ethical dilemma in utilizing versus discarding organs from potential donors succumbing to VITT. This consensus statement is an attempt by the National Organ and Tissue Transplant Organization (NOTTO) apex technical committees, India, to formulate the guidelines for deceased organ donation and transplantation in relation to VITT to help in appropriate decision-making. VITT is a rare entity, but a meticulous approach should be taken by the organ procurement organization's (OPO) team in screening such cases. All such cases must be strictly notified to the national authorities (NOTTO) as a resource for data collection and ensuring compliance with protocols in the management of adverse events following immunization. Organs from any patient who developed thrombotic events up to 4 weeks after adenoviral vector-based vaccination should be considered to be linked to VITT and investigated appropriately. The viability of the organs must be thoroughly checked by the OPO, and the final decision in relation to organ use should be decided by the expert committee of the OPO team consisting of a virologist, a hematologist, and a treating team. Considering the organ shortage, in case of suspected/confirmed VITT, both clinicians and patients should consider the risk‒benefit equation based on limited experience. An appropriate written informed consent of potential recipients and family members should be obtained before the transplantation of organs from suspected or proven VITT donors.
- Published
- 2022
- Full Text
- View/download PDF
5. Safety and Efficacy of Modified FOLFIRINOX in Unresectable or Metastatic Gallbladder Cancer: A Phase II Pilot Study
- Author
-
Atul Sharma, Raja Pramanik, Akash Kumar, Sushmita Pathy, Sunil Kumar, Sandeep Bhoriwal, Sanjay Thulkar, Nihar Ranjan Dash, Sujoy Pal, Priyanshu Choudhary, Satyajit Pawar, Rakesh Kumar, and Gaurav Gupta
- Subjects
Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
PURPOSEFor unresectable gallbladder cancer (GBC), gemcitabine and platinum is standard combination; however, outcome is poor. We conducted this study to find feasibility of modified flourouracil, oxaliplatin, and irinotecan in this group.MATERIALS AND METHODSWe conducted a prospective, phase II single-arm pilot study. Inclusion criteria were histologically proven GBC and Eastern Cooperative Oncology Group 0-1. Primary end points were overall response rates and overall survival. The following treatment was given: oxaliplatin 85 mg/m2, leucovorin 400 mg/m2, and irinotecan 150 mg/m2, all once on day 1, fluorouracil 2,400 mg/m2 continuous intra-venous infusion over 46 hours repeated every 2 weeks, and maximum 12 doses, with primary granulocyte colony-stimulating factor prophylaxis.RESULTSBetween February 2019 and July 2020, 29 patients with unresectable GBC were enrolled. The median age was 52 years, and 18 were females. The Eastern Cooperative Oncology Group was 0 in 4. Five had bilirubin > normal, and 15 each had high serum alkaline phosphatase and carbohydrate antigen 19-9. Twenty-five patients had stage IV disease, and remaining unresectable locally advanced disease. A median of 8.5 cycles was given, and 11 completed treatment. Nine stopped chemotherapy because of progression, and one because of toxicity, and treatment is ongoing in three. Twenty-two required dose reduction. A treatment delay of 1-2 weeks was seen in 25 patients. Best response was complete response 1, partial response 13 (overall response rate 48.2%), and stable disease 9. Four patients with metastatic disease underwent R0 resection. As on cutoff date, nine are surviving (three without disease). Eighteen died of PD, and in two, cause was unknown. There was no toxic death. The median overall survival and progression-free survival were 309 and 252 days, respectively. Twenty-three patients experienced grade III or IV toxicity, and common were diarrhea (13), vomiting (12), and anemia (7).CONCLUSIONFirst-line modified flourouracil, oxaliplatin, and irinotecan is feasible in unresectable GBC with encouraging responses. Toxicities are higher but manageable. Higher response rates make this an option to explore in borderline resectable cases.
- Published
- 2021
- Full Text
- View/download PDF
6. Histological analyses of trucut liver biopsies from patients with noncirrhotic portal fibrosis and extra-hepatic portal vein obstruction
- Author
-
Archana George Vallonthaiel, Vandana Baloda, Lavleen Singh, Rajni Yadav, Ragini Kilambi, Sudha Battu, Vishnubhatla Sreenivas, Sujoy Pal, Subrat K Acharya, Siddhartha DattaGupta, Shalimar, and Prasenjit Das
- Subjects
extra-hepatic portal vein obstruction ,histology ,noncirrhotic portal fibrosis ,portal hypertension ,portal vein ,Pathology ,RB1-214 ,Microbiology ,QR1-502 - Abstract
Background: Both noncirrhotic portal fibrosis (NCPF) and extrahepatic portal venous obstruction (EHPVO) are important causes of noncirrhotic portal hypertension (PH) in the Asian region. In this study, we analyzed the histopathological changes of liver needle-core biopsies from patients with NCPF and EHPVO. Patients and Methods: The patients were diagnosed as per the Asia Pacific Association for the Study of Liver (APASL) criteria. Minimum adequacy criteria for liver core biopsies were defined, and finally, 69 liver biopsies from patients with NCPF and 100 liver biopsies from patients with EHPVO were analyzed. All histological parameters were predefined, and three experienced pathologists analyzed the biopsies after reaching consensus. Institute ethics committee clearance was taken. Results: Although some histological features were overlapping, phlebosclerosis of intra-hepatic branches of the portal vein (PV), periportal aberrant vascular channels, remnant portal tracts, and hepatic fibrosis beyond the portal tracts without the formation of complete hepatic nodules (P < 0.001 for all) were common histological characteristics of NCPF on core-needle liver biopsies; while maintained lobular architecture, nonspecific dilatation of PV branches, absence of intra-hepatic PV phlebosclerosis, aberrant vascular channels, and significant fibrosis were characteristics of EHPVO. Conclusions: Despite the considerable histological overlap between NCPF and EHPVO, careful histological evaluation, supplemented by clinical features, radiological and biochemical findings can help in making a conclusive diagnosis. Patients with NCPF and EHPVO with clinical jaundice show transaminitis, high serum alkaline phosphatase level, more variceal bleed, and histological evidences of nodular regenerative hyperplasia.
- Published
- 2021
- Full Text
- View/download PDF
7. Antiproliferative, Apoptotic, and Antimigration Property of Ethyl Acetate Extract of Calocybe indica against HeLa and CaSki Cell Lines of Cervical Cancer, and its Antioxidant and Mycochemistry Analysis
- Author
-
Swapan Ghosh, Tanmay Bera, and Sujoy Pal
- Subjects
mushroom ,cervical cancer ,cytotoxicity ,apoptosis ,metastasis ,bioactive compounds ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Background: The incidence rate of cervical cancer is increasing and its existing drugs are becoming more and more resistant. Therefore, we extracted the fruiting body of Calocybe indica edible mushroom in 90% ethyl acetate extract (EAE) and evaluated it as an anticancer property against HeLa and CaSki. Method: We performed cytotoxicity assay by MTT, cell morphological study by phase contrast microscope, and apoptosis study by nuclear morphology via DAPI staining under inverted microscopy; the expressions of proapoptotic and antiapoptotic genes and p53 were examined by Western blotting, cell cycle analysis, and cologenic and cell migration assay. Antioxidant content and activity assays were performed and for mycochemistry analysis of EAE, thin layer chromatography (TLC) was done. Results: EAE-treated HeLa and CaSki cells became round and showed condensed and fragmented nuclei. They inhibited the cell proliferation of both cancer cell lines in a dose-dependent manner. At maximum dose (1250 μg/mL) after 24 h, the cell inhibition percentages of HeLa and CaSki cells were 97.12±10.01 and 98.52±10.08 (PConclusion: The EAE of C. indica exerts very potent anticervical cancer effects. It is urgent that future studies analyze its bioactive compounds in detail and examine them in animal models.
- Published
- 2020
- Full Text
- View/download PDF
8. Surgical Management of Life Threatening Bleeding after Endoscopic Cystogastrostomy
- Author
-
Ashish George, Rajesh Panwar, and Sujoy Pal
- Subjects
endoscopic cystogastrostomy ,endoscopic ultrasound ,complications ,bleeding ,surgery ,transgastric ,Surgery ,RD1-811 - Abstract
Postprocedural bleeding is a rare but life threatening complication of endoscopic cystogastrostomy which may require surgical management in some patients. The presence of adhesions and inflammation due to antecedent acute pancreatitis, difficult location of the bleeding site and breach in the posterior wall of stomach pose significant challenges during the surgical management. Here we have described the surgical approach and technique that we used to manage three patients who required surgery for life threatening bleeding after endoscopic cystogastrostomy.
- Published
- 2018
- Full Text
- View/download PDF
9. Are Truelove and Witts criteria for diagnosing acute severe colitis relevant for the Indian population? A prospective study
- Author
-
Saransh Jain, Saurabh Kedia, Sawan Bopanna, Dawesh P Yadav, Sandeep Goyal, Peush Sahni, Sujoy Pal, Nihar Ranjan Dash, Govind Makharia, Simon P. L. Travis, and Vineet Ahuja
- Subjects
Acute severe colitis ,Definition ,Anemia ,Truelove and Witts criteria ,India ,Medicine ,Diseases of the digestive system. Gastroenterology ,RC799-869 - Abstract
Background/AimsTruelove and Witts criteria have been used to define acute severe colitis since the 1950s. However, hemoglobin (an additional criterion of the definition) levels in the general population in developing countries are lower than in the population of developed countries. We aimed to determine the relevance of Truelove and Witts criteria in the Indian population.MethodsConsecutive patients with acute severe colitis satisfying the Truelove and Witts criteria, hospitalized at a single center between April 2015 and December 2016 were included. All patients received intravenous corticosteroids and 16 required colectomy. The hemoglobin levels at admission were subsequently excluded from the classification criteria, and the effect this had on the criteria for diagnosis was determined.ResultsOut of 61 patients of acute severe colitis diagnosed according to the original Truelove and Witts criteria, 12 patients (20%) had 1 additional criterion, 33 (54%) had 2 additional criteria and 16 (26%) had 3 or more additional criteria in addition to 6 or more blood stained stools on admission. On excluding hemoglobin as an additional criterion from the Truelove and Witts definition, all patients still met the criteria for acute severe colitis.ConclusionsTruelove and Witts criteria can be used to define acute severe colitis in India, despite lower mean hemoglobin in the native population.
- Published
- 2018
- Full Text
- View/download PDF
10. Topographic, histological and molecular study of aberrant crypt foci identified in human colon in different clinical groups
- Author
-
Shouriyo Ghosh, Brijnandan Gupta, Pavan Verma, Sreenivas Vishnubathla, Sujoy Pal, Nihar R Dash, Siddhartha Datta Gupta, and Prasenjit Das
- Subjects
Aberrant crypt foci ,Chromoendoscopy ,Medicine ,Diseases of the digestive system. Gastroenterology ,RC799-869 - Abstract
Background/AimsAberrant crypt foci (ACF) are early microscopic lesions of the colonic mucosa, which can be detected by magnified chromoendoscopy. Herein, we have investigated whether ACF identified in different clinical groups can be differentiated based on their characteristics.MethodsMacroscopically unremarkable mucosal flaps were collected from 270 fresh colectomies and divided into 3 clinical groups: colorectal carcinoma (group A), disease controls having known pre-neoplastic potential (group Bc), and disease controls without risk of carcinoma development (group Bn). Topographic and histologic analysis, immunohistochemistry, and molecular studies (high-resolution melt curve analysis, real-time polymerase chain reaction, and Sanger sequencing) were conducted for certain neoplasia-associated markers.ResultsACF were seen in 107 cases, out of which 72 were left colonic ACF and 35 right colonic ACF (67.2% vs. 32.7%, P=0.02). The overall density of left colonic ACF was 0.97/cm, which was greater than the right colonic ACF density of 0.81/cm. Hypercrinia was present in 41 out of 72 left colonic ACF and in 14 out of 35 right colonic ACF (P=0.01). Immunohistochemical expression of p53 was also greater in left colonic ACF than in right colonic ACF (60.5% vs. 38.2%, P=0.03). However, ACF identified among the 3 clinical groups did not show any distinguishing topographic, histological, or genetic changes.ConclusionsLeft colonic ACF appear to be high-risk based on their morphological and prototypic tumor marker signature. ACF identified in different clinical groups do not show significant genotypic or topographic differences. Further detailed genetic studies are required to elucidate them further.
- Published
- 2018
- Full Text
- View/download PDF
11. Predictive factors for malignancy in undiagnosed isolated small bowel strictures
- Author
-
Ujjwal Sonika, Sujeet Saha, Saurabh Kedia, Nihar Ranjan Dash, Sujoy Pal, Prasenjit Das, Vineet Ahuja, and Peush Sahni
- Subjects
Small intestinal stricture ,Crohn disease ,Tuberculosis ,Neoplasms ,Medicine ,Diseases of the digestive system. Gastroenterology ,RC799-869 - Abstract
Background/Aims: Patients with small bowel strictures have varied etiologies, including malignancy. Little data are available on the demographic profiles and etiologies of small bowel strictures in patients who undergo surgery because of intestinal obstruction but do not have a definitive pre-operative diagnosis.Methods: Retrospective data were analyzed for all patients operated between January 2000 and October 2014 for small bowel strictures without mass lesions and a definite diagnosis after imaging and endoscopic examinations. Demographic parameters, imaging, endoscopic, and histological data were extracted from the medical records. Univariate and multivariate analyses were conducted to identify factors that could differentiate between intestinal tuberculosis (ITB) and Crohn's disease (CD) and between malignant and benign strictures.Results: Of the 7,425 reviewed medical records, 89 met the inclusion criteria. The most common site of strictures was the proximal small intestine (41.5%). The most common histological diagnoses in patients with small bowel strictures were ITB (26.9%), CD (23.5%), non-specific strictures (20.2%), malignancy (15.5%), ischemia (10.1%), and other complications (3.4%). Patients with malignant strictures were older than patients with benign etiologies (47.6±15.9 years vs. 37.4±16.4 years, P=0.03) and age >50 years had a specificity for malignant etiology of 80%. Only 7.1% of the patients with malignant strictures had more than 1 stricture and 64% had proximally located strictures. Diarrhea was the only factor that predicted the diagnosis of CD 6.5 (95% confidence interval, 1.10–38.25; P=0.038) compared with the diagnosis of ITB.Conclusions: Malignancy was the cause of small bowel strictures in approximately 16% patients, especially among older patients with a single stricture in the proximal location. Empirical therapy should be avoided and the threshold for surgical resection is low in these patients.
- Published
- 2017
- Full Text
- View/download PDF
12. Presentation and Management of Pseudoaneurysmogastric Fistula: A Life Threatening Emergency
- Author
-
Nihar Ranjan Dash, Ragini Kilambi, Anand Narayan Singh, Sujoy Pal, and Mohammed Adil Asfan
- Subjects
pseudoaneurysmogastric fistula ,hematemesis ,ugi hemorrhage ,pseudoaneurysm ,pancreatitis ,Surgery ,RD1-811 - Abstract
Pseudoaneurysmogastric fistula is a rare consequence of pseudoaneurysms occurring in the vicinity of stomach. They are the result of pseudoaneurysms eroding into the stomach, and represent a life threatening emergency. Urgent surgical intervention is often necessary to salvage the patient. Data regarding the presentation and management of this condition is sparse. Herein, we present our experience with four cases of pseudoaneurysmogastric fistula, their clinical context, presentation, management and outcomes. We attempt to outline an algorithm for the diagnosis and management of this unusual complication.
- Published
- 2017
- Full Text
- View/download PDF
13. Spectrum of hepatobiliary cystic lesions: A 7-year experience at a tertiary care referral center in North India and review of literature
- Author
-
Prasenjit Das, Pragya Sharma, Tripti Nakra, Shouriyo Ghosh, Rajni Yadav, Brijnandan Gupta, Gaurav Khanna, K S Madhusudhan, Rajesh Panwar, M K Anoop, Ragini Kilambi, Anand N Singh, Nihar R Dash, Sujoy Pal, and Siddhartha Datta Gupta
- Subjects
Biliary cyst ,choledocal cyst ,hepatic cyst ,hepatobiliary cystic lesions ,histological spectrum ,hydatid cyst ,Pathology ,RB1-214 ,Microbiology ,QR1-502 - Abstract
Context: Cysts arising from the hepatobiliary tree are a group of heterogeneous lesions with regard to pathogenesis, clinical presentation, and radiological finding. They can be intrahepatic or extrahepatic, developmental, secondary to infective/inflammatory etiologies, as well as neoplastic. This study was conducted to determine the spectrum of hepatobiliary cysts in surgically intervened cases, with regard to their prevalence, histological spectrum, and clinicoradiological correlation, wherever possible. Methods: In this retrospective observational study, hematoxylin and eosin stained slides of all cases of hepatobiliary cystic lesions, operated between 2009 and 2016 were reviewed. Special stains as reticulin, Masson's trichrome, and periodic acid Schiff were done wherever necessary. Overall prevalence, age-sex distribution, clinical presentation and histopathological patterns were studied. Relevant imaging findings were correlated wherever possible. Results: A total of 312 cases of hepatobiliary cysts were identified, the majority in females. Choledochal cysts (CCs) were the most common type (n = 198,63.5%), followed by hydatid cysts (n = 73,23.3%), simple hepatic cysts (n = 10,3.2%), congenital hepatic fibrosis (n = 10,3.2%), biliary cystadenomas (n = 4,1.2%) hepatic mesenchymal hamartomas (n = 7,2.2%), and cavernous hemangiomas (n = 3,0.9%). Fibropolycystic liver disease (n = 2,0.6%), Caroli's disease (n = 1, 0.3%), liver abscess (n = 2, 0.6%), infantile hemangioendothelioma (n = 1,0.3%), and biliary cystadenocarcinomas (n = 1,0.3%) were rare. Lesions noted mostly in 1st decade of life were: CCs, fibrocystic liver disease, Caroli's syndrome, cystic mesenchymal hamartoma, and infantile hemangioendotheliomas. Conclusion: In our cohort of surgically intervened cases of hepatobiliary cystic lesions from a tertiary care hospital in North India, the CCs, followed by hydatid cyst were the most common lesions. Histology can play vital role in characterization, as often clinical findings and radiology can overlap.
- Published
- 2017
- Full Text
- View/download PDF
14. Malignant Schwannoma of the Esophagus: A Rare Case Report
- Author
-
Biswajit Mishra, Kumble Seetharama Madhusudhan, Ragini Kilambi, Prasenjit Das, Sujoy Pal, and Deep Narayan Srivastava
- Subjects
Schwannoma ,Neurilemmoma ,X-ray computed tomography ,Esophagogastric junction ,Surgery ,RD1-811 - Abstract
Neurogenic tumors are the most prevalent tumors of the mediastinum, and schwannomas are the most common type of neurogenic tumor. Primary neurogenic neoplasm of the esophagus is uncommon and malignant schwannoma of the esophagus is extremely rare. We report a case of a 27-year-old female presenting with dysphagia and palpitations who was found to have a lobulated tumor in the mediastinum that was compressing the esophageal lumen. The tumor was successfully treated surgically without recurrence. The final diagnosis, on histopathological examination of the specimen, was malignant schwannoma.
- Published
- 2016
- Full Text
- View/download PDF
15. Encountering epidemic effects of leaf spot disease (Alternaria brassicae) on Aloe vera by fungal biocontrol agents in agrifields-An ecofriendly approach.
- Author
-
Swapan Kumar Ghosh, Subhankar Banerjee, Sujoy Pal, and Niloy Chakraborty
- Subjects
Medicine ,Science - Abstract
Aloe vera (L.) Burm.f. is a highly important and extensively cultivated medicinal plant and that is also extensively used in the cosmetic industry. It has been frequently reported to suffer from Alternaria leaf spot disease in various parts of the world. Various fungicides used to combat this disease, have deleterious effects on the environment and on pharmacologically important constituents of Aloe vera. To avoid the harmful effects of fungicides an ecofriendly approach has been adopted here. A weekly survey was conducted during 2013-2015 in and around North 24 Parganas (West Bengal) to obtain the percentage of disease index (PDI). For biological control of the disease, screening of the antagonistic efficacy of biocontrol agents was carried out through the in vitro dual-culture-plate method and scanning electron microscopy (SEM) was used to study the mechanism. The in vitro effects of fungicides on the radial growth of the pathogen were evaluated through the poison food method and were compared with potent antagonistic fungi. Field application of potent antagonistic fungi was conducted through the dip-and-spray method. The results showed that, the PDI peaked during the hot and humid conditions of May to September (76.57%-98.57%) but decreased during the winter, December-January (35.71-46.66%). Trichoderma asperellum exerted the greatest inhibition of the radial growth of A. brassicae acting through non volatile (70.39%) and volatile metabolites (72.17%). A SEM study confirmed the hyperparasitic nature of T. asperellum through hyphal coiling-T. asperellum was similar to 2% blitox-50 (73.92%) and better than 2% bavistin (59.77%) (in vitro). In agricultural field trials (2013-15), Trichoderma application restricted the disease to the smallest area (PDI 24.00-29.33%) in comparison to untreated plots (73.33%). In conclusion, saplings treated with the dip method (108 spores / mL) and sprayed 4 times with a spore suspension of biocontrol agents such as T. asperellum, T. viride and T. harzianum, standardized at a rate of 2.5 L / plot (36 sq ft) (108 spores/ mL) are suggested for the ecofriendly management of this epidemic leaf spot disease of Aloe vera in agricultural fields.
- Published
- 2018
- Full Text
- View/download PDF
16. Splenectomy in cirrhosis with hypersplenism: improvement in cytopenias, child's status and institution of specific treatment for hepatitis C with success
- Author
-
Saurabh Kedia, Rohit Goyal, Vivek Mangla, Ajay Kumar, S. Shalimar, Prasenjit Das, Sujoy Pal, Peush Sahni, and Subrat K. Acharya, M.D., D.M
- Subjects
Child's score ,Compesated cirrhosis ,HCV ,Interferon ,Open splenectomy ,Specialties of internal medicine ,RC581-951 - Abstract
Introduction. Hypersplenism in cirrhosis is not infrequent and may compromise with quality of life and therapy. Splenectomy is a therapeutic option, but information on results of splenectomy is scarce.Material and methods. Consecutive patients with cirrhosis who underwent splenectomy between 2001-2010 were included in the study. Safety, efficacy of splenectomy and subsequent influence on therapy were evaluated.Results. Thirty three patients (mean age 30.9 ± 11.6 years, 19 men, viral 48.5%, autoimmune 15.1%, cryptogenic 36.4%) underwent splenectomy. Twenty were Child's A, 13 Child's B. Twenty patients had > 6 months follow up. Common indications were inability to treat with interferon, transfusion-dependent anemia, recurrent mucosal bleeds, and large spleen compromising quality of life. Median hospital stay was 7 (4-24) days. There was no splenectomy related mortality. Twenty three (70%) patients had post-operative complications, most commonly infections. Two patients required percutaneous drainage of post-operative collections, and 1 needed re-exploration for intra-abdominal bleed. Subsequent to splenectomy platelet count (44,000 to 151,000/mm3, p < 0.01) and TLC (2,500 to 13,400/mm3, p < 0.01) had sustained increase in all patients except one. Five HCV cirrhotics completed interferon and ribavirin therapy, 4 achieved sustained viral response. The quality of life improved and there was no recurrence of infections, mucosal bleed or anemia requiring transfusions in any patient. In patients on long term follow up (median duration 27 months), the median Child's score improved from 6 at baseline to 5 at follow up (p < 0.05).Conclusions. Splenectomy was safe and effective in patients with cirrhosis, and improved therapeutic options as well as Child's score.
- Published
- 2012
- Full Text
- View/download PDF
17. Insulinoma - The incremental value of somatostatin receptor positron emission tomography
- Author
-
S T Arunraj, Nishikant Avinash Damle, Chandrasekhar Bal, Yashdeep Gupta, and Sujoy Pal
- Subjects
Diseases of the endocrine glands. Clinical endocrinology ,RC648-665 ,Diseases of the digestive system. Gastroenterology ,RC799-869 - Published
- 2017
- Full Text
- View/download PDF
18. Percutaneous transhepatic portal vein stenting in a patient with benign non-transplant postoperative portal vein stenosis: A case report
- Author
-
KS Madhusudhan, Nikhil Agrawal, Deep N Srivastava, Sujoy Pal, and Arun K Gupta
- Subjects
portal hypertension ,portal vein stenosis ,portal vein stenting ,Medical physics. Medical radiology. Nuclear medicine ,R895-920 - Abstract
Extrahepatic portal vein stenosis is caused by a variety of benign and malignant diseases and results in development of symptoms due to portal hypertension. Benign post-surgical adhesions causing portal vein stenosis in non-transplant population is an uncommon etiology of portal hypertension. Endovascular treatment of such patients with angioplasty and stenting is uncommonly reported in literature. We report a case of portal hypertension caused by benign postoperative portal vein fibrosis, successfully treated by self-expandable metallic stent.
- Published
- 2013
- Full Text
- View/download PDF
19. Asymptomatic Transhiatal Pancreatic Herniation after Oesophagectomy
- Author
-
Nikhil Agrawal, Sujoy Pal, Nihar Ranjan Dash, KS Madhusudha, and Deep Narayan Srivastava
- Subjects
carcinoma oesophagus ,complication ,hernia ,oesophagectomy ,pancreas ,Medicine - Abstract
Transhiatal herniation of abdominal organs after oesophageal resection and reconstruction is rare and sparsely described in the literature. The commonest organ to herniate is the colon. Pancreatic herniation has been reported twice before. We report a case of postoesophagectomy transhiatal pancreatic herniation in an asymptomatic patient.
- Published
- 2014
- Full Text
- View/download PDF
20. Role of Vitamin E in Ischaemic Skin Flap Survival in Rats
- Author
-
Rakesh K Khazanchi, Sujoy Pal, Deepak Mital, Kalpana Gupta, Sandeep Guleria, and Vipul Nanda
- Subjects
Surgery ,RD1-811 - Abstract
The efficacy of free radical scavenger – Vitamin E (VE) in salvage of ischaemic skin flaps was studied in an experimental rat skin flap model. The animals were divided into two groups – a control group (N=15) who did of receive VE and a test group (N=15) who received VE starting one week preoperatively. No significant difference was found in flap necrosis between the control group (38.365% ± 1.398% SEM) and the test group (35.288% ± 0.635% SEM), which received therapeutic dose of VE (100 mg/kg/day. 1 mg = 1.49 I.U). Further research is needed to establish the role of vitamin E as an agent of ischaemic skin flap salvage.
- Published
- 1995
- Full Text
- View/download PDF
21. National Liver Allocation Policy—Consensus Document by the Liver Transplantation Society of India for a Nationally Uniform System of Allocation of Deceased Donor Liver Grafts
- Author
-
Mettu S. Reddy, Surendra K. Mathur, Surendran Sudhindran, Subhash Gupta, Mohamed Rela, Arvinder S. Soin, Darius Mirza, Sonal Asthana, Madhusudhan Chinthakindi, Mathew Jacob, Vinay Kumaran, Pranjal Modi, Ravi Mohanka, Gomathy Narasimhan, Sujoy Pal, Viniyendra Pamecha, Amit Rastogi, Sanjiv Saigal, and Manav Wadhawan
- Subjects
Hepatology - Published
- 2023
- Full Text
- View/download PDF
22. Benign Hepatic Nodules in Patients With Primary Extrahepatic Portal Vein Obstruction: Clinical and Magnetic Resonance Imaging Features
- Author
-
Kapil, Semalti, Ragini, Kilambi, Sujoy, Pal, Deep N, Srivastava, Peush, Sahni, and Kumble S, Madhusudhan
- Subjects
Hepatology - Abstract
To retrospectively evaluate the magnetic resonance imaging (MRI) features of benign hepatic nodules in patients with extrahepatic portal vein obstruction (EHPVO) and assess predictable features for their development.This retrospective observational study included 18 diagnosed patients of EHPVO who underwent contrast enhanced abdominal MRI at our Institute between June 2016 and May 2017, and who could be followed up for at least two years. The patients with liver nodules formed the study group (n = 8; 4 males, 4 females; mean age: 26.1 ± 10.9 years) and patients without liver nodules were controls (n = 10; 3 males, 7 females; mean age: 24.2 ± 15.1 years). Liver nodules were confirmed as benign by either biopsy or stability on follow up imaging. MRI features of liver nodules were assessed. Clinical details and imaging data of the study group were compared with controls to assess predictable features.There was no statistically significant difference in age, gender, clinical characteristics and upper gastrointestinal endoscopic findings between the study and control groups. The size of the lienorenal collateral, left renal vein and superior mesenteric vein were significantly larger in the study group (Liver nodules in patients with EHPVO are likely to be benign and have characteristic MRI features. Significantly larger lienorenal collateral, left renal vein and superior mesenteric vein were associated with the development of these nodules.
- Published
- 2022
- Full Text
- View/download PDF
23. Management and outcomes of pseudoaneurysms presenting with late hemorrhage following pancreatic surgery: A six-year experience from a tertiary care center
- Author
-
Jayapal Rajendran, Rajesh Panwar, Anand Narayan Singh, Nihar Ranjan Dash, Sujoy Pal, Deep Narayan Srivastava, Peush Sahni, and Kumble Seetharama Madhusudhan
- Subjects
Gastroenterology - Published
- 2023
- Full Text
- View/download PDF
24. A Prospective Study Comparing Billroth II and Roux-en-Y Gastrojejunostomy in Patients with Carcinoma Stomach
- Author
-
Prasad, Ravella Vishnu, primary, Ranjan, Dash Nihar, additional, Prasad, Samantaray Satya, additional, Sujoy, Pal, additional, and Peush, Sahni, additional
- Published
- 2023
- Full Text
- View/download PDF
25. Heterogeneity in Antimicrobial Resistance Potency and Functionality Among Multidrugresistant Gram-Negative Pathogens: Phenotypic, Genotypic and Proteomic Analysis
- Author
-
Tanshi Mehrotra, Dipasri Konar, Agila Kumari Pragasam, Shakti Kumar, Pradipta Jana, Prabhakar Babele, Deepjyoti Paul, Ayushi Purohit, Subhash Tanwar, Susmita Bakshi, Santanu Das, Jyoti Verma, Daizee Talukdar, Lekshmi Narendrakumar, Akanksha Kothidar, Sonali Porey Karmakar, Susmita Chaudhuri, Sujoy Pal, Kajal Jain, Chittur V. Srikanth, Jeeva Sankar, Krishnamohan Atmakuri, Ramesh Agarwal, Rajni Gaind, Mamatha Ballal, Nagamani Kammili, Rupak K Bhadra, Thandavarayan Ramamurthy, and Bhabatosh Das
- Published
- 2023
- Full Text
- View/download PDF
26. A REVIEW ON THE BEETLE - POLLINATION IN INDIA
- Author
-
Akash Paul, Rishiraj Debnath, Soudip Karmakar, Rajat Roy, Sujoy Pal, and Bulganin Mitra
- Published
- 2021
- Full Text
- View/download PDF
27. POLLINATION STRATEGIES OF ORCHIDACEAE WITH SPECIAL REFERENCE TO INDIA: A REVIEW
- Author
-
Rupak Mahapatra, Riddhiman Debnath, Somyajit Pal, and Sujoy Pal
- Published
- 2021
- Full Text
- View/download PDF
28. CT-Guided Transhepatic Catheter Drainage of Deep Postoperative Collections: Initial Experience
- Author
-
Akhil Baby, Danny Joy, Nihar R. Dash, Sujoy Pal, Deep N. Srivastava, and Kumble S. Madhusudhan
- Subjects
Medical physics. Medical radiology. Nuclear medicine ,interventional radiology ,postop collection drainage ,R895-920 ,Radiology, Nuclear Medicine and imaging ,computed tomography guided drainage - Abstract
Purpose This article assesses the safety and utility of transhepatic drainage of deep seated postoperative intra-abdominal collections under computed tomography (CT) guidance in a short series. Methods This retrospective study included five patients (mean age: 45.8 years; 3 males, 2 females) who underwent CT-guided transhepatic drainage of postoperative abdominal abscess in our department between April 2019 and December 2020. The clinical and surgical details and the details of the transhepatic drainage procedure were evaluated along with success rates and complications. Results The surgical procedures were Whipple's pancreaticoduodenectomy in four patients and gastrectomy in one patient. Four out of five abscesses were drained through the right lobe of liver, while one was through the left lobe with a technical success rate of 100%. The mean total time for catheter drainage procedure including patient positioning and preparation was 29.2 minutes. None of the patients had procedure-related complications. Mean duration of catheter drainage was 12 days. All patients had complete resolution of symptoms after drainage and the clinical success rate was 100%. Conclusion Transhepatic approach is safe and effective for the drainage of inaccessible postoperative abdominal collections or abscesses where a standard percutaneous approach is not possible.
- Published
- 2021
- Full Text
- View/download PDF
29. Safety and Efficacy of Modified FOLFIRINOX in Unresectable or Metastatic Gallbladder Cancer: A Phase II Pilot Study
- Author
-
Sushmita Pathy, Akash Kumar, Gaurav Gupta, Sandeep Bhoriwal, Satyajit Pawar, Sujoy Pal, Rajesh Kumar, Sanjay Thulkar, Sunil Kumar, Priyanshu Choudhary, Nihar Ranjan Dash, Atul Sharma, and Raja Pramanik
- Subjects
Oncology ,Cancer Research ,medicine.medical_specialty ,FOLFIRINOX ,Leucovorin ,Pilot Projects ,Irinotecan ,Internal medicine ,Antineoplastic Combined Chemotherapy Protocols ,Gastrointestinal Cancer ,Humans ,Medicine ,Prospective Studies ,Gallbladder cancer ,business.industry ,ORIGINAL REPORTS ,Middle Aged ,medicine.disease ,Gemcitabine ,Oxaliplatin ,Pancreatic Neoplasms ,Female ,Gallbladder Neoplasms ,Fluorouracil ,business ,Unresectable gallbladder cancer ,medicine.drug - Abstract
PURPOSE For unresectable gallbladder cancer (GBC), gemcitabine and platinum is standard combination; however, outcome is poor. We conducted this study to find feasibility of modified flourouracil, oxaliplatin, and irinotecan in this group. MATERIALS AND METHODS We conducted a prospective, phase II single-arm pilot study. Inclusion criteria were histologically proven GBC and Eastern Cooperative Oncology Group 0-1. Primary end points were overall response rates and overall survival. The following treatment was given: oxaliplatin 85 mg/m2, leucovorin 400 mg/m2, and irinotecan 150 mg/m2, all once on day 1, fluorouracil 2,400 mg/m2 continuous intra-venous infusion over 46 hours repeated every 2 weeks, and maximum 12 doses, with primary granulocyte colony-stimulating factor prophylaxis. RESULTS Between February 2019 and July 2020, 29 patients with unresectable GBC were enrolled. The median age was 52 years, and 18 were females. The Eastern Cooperative Oncology Group was 0 in 4. Five had bilirubin > normal, and 15 each had high serum alkaline phosphatase and carbohydrate antigen 19-9. Twenty-five patients had stage IV disease, and remaining unresectable locally advanced disease. A median of 8.5 cycles was given, and 11 completed treatment. Nine stopped chemotherapy because of progression, and one because of toxicity, and treatment is ongoing in three. Twenty-two required dose reduction. A treatment delay of 1-2 weeks was seen in 25 patients. Best response was complete response 1, partial response 13 (overall response rate 48.2%), and stable disease 9. Four patients with metastatic disease underwent R0 resection. As on cutoff date, nine are surviving (three without disease). Eighteen died of PD, and in two, cause was unknown. There was no toxic death. The median overall survival and progression-free survival were 309 and 252 days, respectively. Twenty-three patients experienced grade III or IV toxicity, and common were diarrhea (13), vomiting (12), and anemia (7). CONCLUSION First-line modified flourouracil, oxaliplatin, and irinotecan is feasible in unresectable GBC with encouraging responses. Toxicities are higher but manageable. Higher response rates make this an option to explore in borderline resectable cases.
- Published
- 2021
- Full Text
- View/download PDF
30. Gallbladder reporting and data system (GB-RADS) for risk stratification of gallbladder wall thickening on ultrasonography: an international expert consensus
- Author
-
Manika Chhabra, Volkan Adsay, Savio G. Barreto, Shraddha Patkar, Atul Sharma, Chandan Krishuna Das, Pratyaksha Rana, Pankaj Gupta, Pramod Kumar Garg, Anu Behari, Mahesh Goel, Giuseppe Garcea, Nitin Shetty, Usha Dutta, Thakur Deen Yadav, Ritambhara Nada, Yashwant Sakaray, Santosh Irrinki, Anu Eapen, Vikas Gupta, Juan Carlos Roa, Manphool Singhal, Bhawna Sirohi, Daneshwari Kalage, Raju Sharma, Ho-Seong Han, Avinash Kambadakone, Raghuraman Soundararajan, Ajay Gulati, Naveen Kalra, Radhika Srinivasan, Robbert J. de Haas, Anil Kumar Agarwal, Amol Patel, Milind Javle, Flavio Nervi, Manavjit Singh Sandhu, Vinay Kumar Kapoor, Harmeet Kaur, Uma Nahar Saikia, Harjeet Singh, Sujoy Pal, Vishal Sharma, and Lileshwar Kaman
- Subjects
medicine.medical_specialty ,Gallbladder wall thickening ,Consensus ,Urology ,Malignancy ,Risk Assessment ,Internal medicine ,medicine ,Data Systems ,Humans ,Radiology, Nuclear Medicine and imaging ,Gallbladder cancer ,Ultrasonography ,Radiological and Ultrasound Technology ,business.industry ,Gallbladder ,Gastroenterology ,Expert consensus ,Hepatology ,medicine.disease ,medicine.anatomical_structure ,Risk stratification ,Radiology ,business - Abstract
The Gallbladder Reporting and Data System (GB-RADS) ultrasound (US) risk stratification is proposed to improve consistency in US interpretations, reporting, and assessment of risk of malignancy in gallbladder wall thickening in non-acute setting. It was developed based on a systematic review of the literature and the consensus of an international multidisciplinary committee comprising expert radiologists, gastroenterologists, gastrointestinal surgeons, surgical oncologists, medical oncologists, and pathologists using modified Delphi method. For risk stratification, the GB-RADS system recommends six categories (GB-RADS 0–5) of gallbladder wall thickening with gradually increasing risk of malignancy. GB-RADS is based on gallbladder wall features on US including symmetry and extent (focal vs. circumferential) of involvement, layered appearance, intramural features (including intramural cysts and echogenic foci), and interface with the liver. GB-RADS represents the first collaborative effort at risk stratifying the gallbladder wall thickening. This concept is in line with the other US-based risk stratification systems which have been shown to increase the accuracy of detection of malignant lesions and improve management. Graphical abstract: [Figure not available: see fulltext.].
- Published
- 2021
- Full Text
- View/download PDF
31. Challenges of Identity Management - A Context in Rural India.
- Author
-
Rajanish Dass and Sujoy Pal
- Published
- 2009
- Full Text
- View/download PDF
32. Pattern of Aorto-coeliac Calcification Correlating Cervical Esophago-gastric Anastomotic Leak After Esophagectomy for Cancer: a Retrospective Study
- Author
-
Lokesh, Agarwal, Nihar Ranjan, Dash, Sujoy, Pal, Ayushi, Agarwal, and Kumble Seetharaman, Madhusudhan
- Subjects
Oncology ,Gastroenterology - Abstract
Cervical esophagogastric anastomotic leak (CEGAL) is a troublesome complication after esophagectomy and gastric pull-up. The aim of the study was to identify the preoperative clinical and radiological factors associated with increased risk of CEGAL.Consecutive patients whose clinical and imaging data were available and who underwent cervical esophago-gastric anastomosis following esophagectomy and gastric pull-up for esophageal cancer, between January 2013 and January 2021, were included. The patient details were collected from a prospectively maintained database. The demographic, clinical, and laboratory data including preoperative hemoglobin and serum albumin levels were recorded. Preoperative computed tomographic (CT) images were reviewed by two independent radiologists to assign vascular calcification scores for proximal aorta, distal aorta, aortic bifurcation, celiac trunk, and celiac artery branches. The primary outcome evaluated was clinically evident neck leak. Univariate and multivariate analysis of the clinical and radiological factors was performed to identify significant predictors.A total of 100 patients (mean age: 54.7 years; 60 males, 40 females) were included in the study and of them, 27 developed CEGAL. Compared to the group without CEGAL, the patient group with CEGAL had significantly higher mean age (60.3 vs. 52.7 years, p 0.01), and higher incidences of diabetes mellitus (25.9% vs 10.9%, p = 0.03), major proximal aortic calcification (29.6% vs. 6.3%, p 0.01), and major celiac trunk calcification (22.2% vs. 6.3%, p = 0.02). Multivariate regression analysis identified age and presence of major proximal aortic calcification as independent risk factors for the development of CEGAL.Major calcification of the proximal aorta and advanced age are independent risk factors for CEGAL after esophagectomy.
- Published
- 2022
- Full Text
- View/download PDF
33. Surgery for mesenchymal neoplasms of the esophagus: experience over 2 decades from a tertiary healthcare center in India
- Author
-
Lokesh Agarwal, Sujoy Pal, Nihar Ranjan Dash, Kumble Seetharama Madhusudhan, Prasenjit Das, Deepak Gunjan, Peush Sahni, and Tushar Kanti Chattopadhyay
- Subjects
Adult ,Adolescent ,Esophageal Neoplasms ,Leiomyoma ,Tertiary Healthcare ,Middle Aged ,Esophagectomy ,Young Adult ,Treatment Outcome ,Humans ,Surgery ,Female ,Aged ,Retrospective Studies - Abstract
Mesenchymal tumors are the most common benign neoplasms of the esophagus. Owing to the rarity of these neoplasms, there is a dearth of literature regarding their diagnosis and management. Our 2-decade-long experience in managing these neoplasms surgically is presented. Relevant clinical data of all patients with esophageal mesenchymal neoplasms (EMNs) managed between January 2000 and May 2020 were retrospectively collected from a prospectively maintained esophageal diseases database in the Department of GI Surgery, AIIMS, New Delhi (India). Special emphasis was given to data pertaining to diagnostic evaluation of patients, type of surgery done (enucleation vs. resection), postoperative outcomes, histopathology and long-term follow-up. Nineteen patients (12 females; age 15-66 years) underwent surgery for EMN (mean tumor size 7.6 cm; enucleation 10; resection 9). On histopathological examination, 17 cases were noted to be benign esophageal leiomyomas and 2 were identified as gastrointestinal stromal tumors. There was no perioperative mortality. All cases were followed up for a median duration of 6 years (range 1-19 years) with no evidence of recurrence in any case. Though EMNs are uncommon, they are mostly benign, and the long-term outcomes after surgical excision are gratifying.
- Published
- 2022
34. Sepsis Following Liver Biopsy in a Liver Transplant Recipient: Case Report and Review of Literature
- Author
-
Shalimar, Sachin Jain, Peush Sahni, Prasenjit Das, Kumble Seetharama Madhusudhan, Nihar Ranjan Dash, Lokesh Agrawal, and Sujoy Pal
- Subjects
medicine.medical_specialty ,Hepatology ,medicine.diagnostic_test ,business.industry ,medicine.drug_class ,medicine.medical_treatment ,Antibiotics ,Case Report ,Liver transplantation ,Anastomosis ,medicine.disease ,Primary sclerosing cholangitis ,Surgery ,Sepsis ,03 medical and health sciences ,0302 clinical medicine ,030220 oncology & carcinogenesis ,Liver biopsy ,medicine ,030211 gastroenterology & hepatology ,Liver function ,Complication ,business - Abstract
Percutaneous liver biopsy is a relatively safe procedure with low complication rates. Infections following liver biopsy are uncommon and can lead to a poor outcome. There are limited data on liver biopsy–related infections among liver transplant (LT) recipients. Also, there is a paucity of data regarding the use of prophylactic antibiotics in LT patients undergoing percutaneous liver biopsy. We report a case of systemic sepsis following percutaneous liver biopsy in a LT recipient with choledochojejunal anastomosis. This was followed by severe rejection and deterioration of liver function and recurrence of primary sclerosing cholangitis (PSC) to the extent that he has been listed for retransplantation. This case report emphasizes the potential risk of sepsis in LT recipients with bilioenteric anastomosis undergoing percutaneous liver biopsy. This increased risk may warrant periprocedural broad spectrum antibiotic prophylaxis, in this subgroup of patients.
- Published
- 2021
- Full Text
- View/download PDF
35. Combination of sarcopenia and high visceral fat predict poor outcomes in patients with Crohn’s disease
- Author
-
Kumble Seetharama Madhusudhan, Saurabh Kedia, Venigalla Pratap Mouli, Sudheer K. Vuyyuru, Raju Sharma, Govind K. Makharia, Pabitra Sahu, Gurasis Boparai, Peush Sahni, Bhaskar Kante, Vineet Ahuja, Davesh P. Yadav, Nihar Ranjan Dash, Rajesh Panwar, Sujoy Pal, and Devasenathipathy Kandasamy
- Subjects
Male ,0301 basic medicine ,Sarcopenia ,medicine.medical_specialty ,Medicine (miscellaneous) ,030209 endocrinology & metabolism ,Computed tomography ,Disease ,Intra-Abdominal Fat ,Gastroenterology ,03 medical and health sciences ,0302 clinical medicine ,Crohn Disease ,Internal medicine ,medicine ,Humans ,In patient ,Muscle, Skeletal ,Visceral fat ,Retrospective Studies ,Crohn's disease ,030109 nutrition & dietetics ,Nutrition and Dietetics ,medicine.diagnostic_test ,business.industry ,Skeletal muscle ,Retrospective cohort study ,Prognosis ,medicine.disease ,medicine.anatomical_structure ,Female ,business ,human activities - Abstract
Sarcopenia and visceral fat independently predict poor outcomes in Crohn's disease (CD). However, combined influence of these parameters on outcomes is unknown, and was investigated in the present study.This retrospective study evaluated skeletal muscle index (SMI-cross-sectional area of five skeletal muscles normalized for height), visceral and subcutaneous fat area and their ratio (VF/SC) on single-slice computed tomography (CT) images at L3 vertebrae in CD patients (CT done: January 2012-December 2015, patients followed till December 2019). Sarcopenia was defined as SMI 36.5 cmForty-four patients [age at onset: 34.4 ± 14.1 years, median disease duration: 48 (24-95) months, follow-up duration: 32 (12-53.5) months, males: 63.6%] were included. Prevalence of sarcopenia was 43%, more in females, but independent of age, disease severity, behavior and location. More patients with sarcopenia underwent surgery (31.6% vs 4%, p = 0.01). VF/SC was significantly higher in patients who underwent surgery (1.76 + 1.31 vs 0.9 + 0.41, p = 0.002), and a cutoff of 0.88 could predict surgery with sensitivity and specificity of 71% and 65% respectively. On survival analysis, probability of remaining free of surgery was lower in patients with sarcopenia (59.6% vs 94.1% p = 0.01) and those with VF/SC 0.88 (66.1% vs 91.1%, p = 0.1), and still lower in those with both sarcopenia and VF/SC 0.88 than those with either or none (38% vs 82% vs 100%, p = 0.01).Combination of sarcopenia and high visceral fat predict worse outcomes in CD than either.
- Published
- 2021
- Full Text
- View/download PDF
36. De-polymerization of LDPE plastic by Penicillium simplicissimum isolated from municipality garbage plastic and identified by ITSs locus of rDNA
- Author
-
Swapan Kumar Ghosh and Sujoy Pal
- Subjects
0106 biological sciences ,0301 basic medicine ,chemistry.chemical_classification ,Morphology (linguistics) ,Strain (chemistry) ,biology ,Chemistry ,Plant Science ,Polymer ,Fungus ,biology.organism_classification ,01 natural sciences ,03 medical and health sciences ,Low-density polyethylene ,030104 developmental biology ,Polymerization ,biology.protein ,Food science ,Lipase ,010606 plant biology & botany ,Plastic bag - Abstract
Plastic bags from garbage were collected and fungi were isolated from these bags and their degradation potentialities of LDPE were screened. Their potentialities were measured by weight loss method, molecular weight reduction by viscosity meter method, surface morphology by SEM and CO2 evolution method. Both treated by ethanol or untreated LDPE were employed. It was observed that out of three fungal isolates, F1 isolate showed maximum degradation while untreated sheets were also degraded by this isolate in more or less percentage of weight loss. Surface morphology analysis under SEM showed degraded areas on F1 treated LDPE. FT-IR analysis showed that F1 influenced the carbonyl group and C=C group formation in polymer. Lipase enzyme was found to be secreted by F1 fungus in culture. The F1 isolate was identified molecularly as Penicillium simplicissimum strain Bar2. This fungus isolate may be used for LDPE waste plastic management.
- Published
- 2021
- Full Text
- View/download PDF
37. Histological analyses of trucut liver biopsies from patients with noncirrhotic portal fibrosis and extra-hepatic portal vein obstruction
- Author
-
Sudha Battu, Siddhartha Dattagupta, Shalimar, Vishnubhatla Sreenivas, Vandana Baloda, Rajni Yadav, Sujoy Pal, Ragini Kilambi, Prasenjit Das, Subrat K. Acharya, Archana George Vallonthaiel, and Lavleen Singh
- Subjects
Microbiology (medical) ,Adult ,Liver Cirrhosis ,medicine.medical_specialty ,noncirrhotic portal fibrosis ,Hepatic portal vein obstruction ,Adolescent ,extra-hepatic portal vein obstruction ,Biopsy ,Portal vein ,Gastroenterology ,Microbiology ,Pathology and Forensic Medicine ,histology ,Young Adult ,Liver Function Tests ,Internal medicine ,Hypertension, Portal ,medicine ,Pathology ,Humans ,RB1-214 ,Child ,Retrospective Studies ,Paraffin Embedding ,business.industry ,Histological Techniques ,portal hypertension ,Histology ,General Medicine ,Middle Aged ,medicine.disease ,Venous Obstruction ,QR1-502 ,Liver ,Portal fibrosis ,Portal hypertension ,Vascular channel ,Hepatic fibrosis ,business ,portal vein - Abstract
Background: Both noncirrhotic portal fibrosis (NCPF) and extrahepatic portal venous obstruction (EHPVO) are important causes of noncirrhotic portal hypertension (PH) in the Asian region. In this study, we analyzed the histopathological changes of liver needle-core biopsies from patients with NCPF and EHPVO. Patients and Methods: The patients were diagnosed as per the Asia Pacific Association for the Study of Liver (APASL) criteria. Minimum adequacy criteria for liver core biopsies were defined, and finally, 69 liver biopsies from patients with NCPF and 100 liver biopsies from patients with EHPVO were analyzed. All histological parameters were predefined, and three experienced pathologists analyzed the biopsies after reaching consensus. Institute ethics committee clearance was taken. Results: Although some histological features were overlapping, phlebosclerosis of intra-hepatic branches of the portal vein (PV), periportal aberrant vascular channels, remnant portal tracts, and hepatic fibrosis beyond the portal tracts without the formation of complete hepatic nodules (P < 0.001 for all) were common histological characteristics of NCPF on core-needle liver biopsies; while maintained lobular architecture, nonspecific dilatation of PV branches, absence of intra-hepatic PV phlebosclerosis, aberrant vascular channels, and significant fibrosis were characteristics of EHPVO. Conclusions: Despite the considerable histological overlap between NCPF and EHPVO, careful histological evaluation, supplemented by clinical features, radiological and biochemical findings can help in making a conclusive diagnosis. Patients with NCPF and EHPVO with clinical jaundice show transaminitis, high serum alkaline phosphatase level, more variceal bleed, and histological evidences of nodular regenerative hyperplasia.
- Published
- 2021
38. Pervasive Business Intelligence: Opportunities and Challenges.
- Author
-
Sujoy Pal and Rajanish Dass
- Published
- 2010
- Full Text
- View/download PDF
39. Right-sided versus left-sided percutaneous transhepatic biliary drainage in the management of malignant biliary obstruction: a randomized controlled study
- Author
-
Deep Narayan Srivastava, Pratik Kumar, Peush Sahni, Nihar Ranjan, Rajendra Kumar Behera, Kumble Seetharama Madhusudhan, Pramod Kumar Garg, and Sujoy Pal
- Subjects
Male ,medicine.medical_specialty ,Urology ,Left sided ,law.invention ,Randomized controlled trial ,Quality of life ,law ,Internal medicine ,Humans ,Medicine ,Fluoroscopy ,Radiology, Nuclear Medicine and imaging ,Major complication ,Cholestasis ,Radiological and Ultrasound Technology ,medicine.diagnostic_test ,business.industry ,Significant difference ,Gastroenterology ,Middle Aged ,Hepatology ,Surgery ,Treatment Outcome ,Quality of Life ,Drainage ,Female ,Percutaneous transhepatic biliary drainage ,business - Abstract
To compare the technical difficulty, safety, radiation exposure and success rates between right-sided and left-sided percutaneous transhepatic biliary drainage (RPTBD and LPTBD) in patients with malignant biliary obstruction (MBO). Fifty patients (28 males, 22 females; mean age 51.78 years) with MBO were randomized to undergo either RPTBD or LPTBD during the study period between June 2016 and May 2018. The procedure time, fluoroscopy time, radiation doses to the operators and patients, technical success, clinical success, complications and effect on quality of life were evaluated and compared between the two groups. Twenty-five patients were included in each group. The technical success was 100% in both groups. There was no significant difference between RPTBD and LPTBD groups in terms of major complications [4% and 12%, respectively; p = 0.297] and minor complications [40% and 32%, respectively; p = 0.597]. Further, the average procedure time (37.80 ± 13.07 min vs 41.04 ± 14.94 min), fluoroscopy time (5.88 ± 4.2 min vs 5.97 ± 3.8 min), radiation doses to the operator (136.84 ± 106.67 μSv vs 130.40 ± 106.46 μSv) and to the patient (8.23 ± 5.80 Gycm2 vs 11.74 ± 11.28 Gycm2) were not significantly different between the groups. Clinical success was achieved in 21 patients (84%) of RPTBD group and 17 patients (68%) of LPTBD group with no significant difference (p = 0.416) between them. There was no significant difference between RPTBD and LPTBD with reference to the technique, safety, radiation dose, success rates and impact on quality of life suggesting no laterality advantage for biliary drainage in cases of MBO.
- Published
- 2020
- Full Text
- View/download PDF
40. Expression analysis of oncogene transcript in human Aberrant Crypt foci, in comparison to the normal colonic mucosa and colorectal carcinoma from formalin-fixed paraffin-embedded tissue samples: A Pilot Study
- Author
-
Mohamed Sulaiman, Jayati Sarangi, Aijaz Ahmed, Shouriyo Ghosh, Lailta Mehra, Brijnandan Gupta, Ashish Datt Upadhyay, Sujoy Pal, Nihar R Dash, Vineet Ahuja, Rajni Yadav, Atul Sharma, SVS Deo, Siddhartha Datta Gupta, and PRASENJIT DAS
- Subjects
digestive system diseases - Abstract
Purpose: Aberrant Crypt Foci (ACF) are microscopic preneoplastic lesions in human colon detectable by magnified chromoendoscopy. Our aim was to analyze the expression of a chosen gene transcript in harvested colonic ACF, corresponding colorectal carcinomas (CRC) and normal mucosa. Methods: A total of 35 cases having ACF >4 in number/ 4 mm2 colonic mucosa were selected from 302 fresh colectomy samples screened along with the corresponding CRC (35) and normal colonic mucosal shavings (20). Gene expression analysis was performed by reverse transcriptase-polymerase chain reaction in these 3-groups. The gene expression data were correlated with histological and topographical ACF types, lymph node metastasis, site, size, and stage of tumors. Results: The KRAS, CDKN1A, CDKN2A, MLH1, VEGFA, and CCL5 gene expressions were significantly altered in ACF compared to controls (p CDNK2A, PTEN (p 0.01), and SMAD4 (p 0.05) were significantly altered in CRC than in controls. The gene expression profile of the mucosal ACF and corresponding CRC foci were similar. No definitive correlation was found between topographic and histological types of ACF and gene expressions. Up-regulation of IGF1 and EGFR genes in ACF were associated with higher lymph node metastases and larger tumor sizes respectively, while down-regulation of RB1 and Bcl2 genes were associated with smaller tumor size. Conclusions The molecular pathogenesis of ACF is as complex as that like advanced CRC foci. Our observation is fascinating as it brings forth the complex pathogenesis of these early mucosa lesions and defies sequential molecular accumulation hypothesis.
- Published
- 2022
- Full Text
- View/download PDF
41. Non-cirrhotic Portal Fibrosis
- Author
-
Vivek Mangla, Shivraj Bahadur Singh, Sujoy Pal, Nabeen Nayak, and Samiran Nundy
- Published
- 2022
- Full Text
- View/download PDF
42. Evaluation of chromatin remodelers in pancreatic neuroendocrine neoplasms
- Author
-
Salma Ferosh Usman Khan, Rajni Yadav, Nihar Ranjan Dash, Sujoy Pal, Prasenjit Das, Anand Narayan, V P Jyotsna, Shamim Ahmed Shamim, Sameer Rastogi, Shipra Agarwal, and Mehar C Sharma
- Subjects
Cancer Research ,Oncology - Abstract
652 Background: Pancreatic neuroendocrine neoplasms (PanNENs) are rare entities comprising 1-2% of gastroenteropancreatic neoplasms with an annual incidence of 0.48/100,000 population in the world. The molecular pathways underpinning the entity are less explored owing to its rarity. We aimed to analyse and correlate the expression of chromatin remodelers in PanNENs from Indian subcontinent. Methods: An ambispective study (prospective 2014-2018 as well as retrospective 2018-2021) was conducted. Haematoxylin and eosin stained slides with immunohistochemistry slides (chromogranin, synaptophysin) of 73 cases of PanNENs were retrieved from archives of Department of Pathology, AlIMS, New Delhi and evaluated for assessment of histopathological parameters. Following slide review, grading and staging were done based on WHO 2017 Classification and AJCC eighth edition respectively. Representative formalin fixed paraffin embedded block was selected after slide review and retrieved for performing immunohistochemical staining with antibodies against ATRX, DAXX, SETD2, H3K36Me3 and ARID1A using Ultra Vision Quanto polymer detection system by Thermo Fisher Scientific. Data was analysed using STATA version SE14. Results: Study cohort of 73 PanNENs had a mean age of presentation 41 years (Range: 8 years -70 years) and male to female ratio of 1.43:1. Majority of the tumors in our study were non functional (63.01%). Loss of nuclear expression of ATRX/DAXX (at least one marker) was seen in 26/73 (35.62%) cases. Loss of expression had significant correlation with pathological stage of the tumor, presence of distant metastasis and adverse prognostic outcome (p value
- Published
- 2023
- Full Text
- View/download PDF
43. Impact of Delay in Adjuvant Chemoradiation on Survival in Resected Gastric Cancer
- Author
-
Raja Pramanik, Sushmita Pathy, Dash Nr, S V Suryanarayana Deo, Sujoy Pal, Nootan Kumar Shukla, Atul Sharma, Shalabh Arora, Sunil Kumar, B. K. Mohanti, Sanjay Thulkar, and Vinod Raina
- Subjects
Oncology ,medicine.medical_specialty ,business.industry ,medicine.medical_treatment ,Internal medicine ,Medicine ,Cancer ,business ,medicine.disease ,Adjuvant - Abstract
BackgroundAdjuvant chemo(radio)therapy is known to improve survival in resected gastric cancer. However, there is scant data on the effect of delay in start of adjuvant treatment (AT) after surgery, and guidelines regarding optimal timing are mostly empirical.MethodsIn this ambispective analysis, we evaluated the survival outcome of patients who underwent upfront curative intent radical gastrectomy followed by AT at our center from 2002 through 2019. Cox proportional hazards model was used to identify predictors of recurrence-free survival (RFS) and overall survival (OS).ResultsTwo-hundred and thirty patients (median age 53 years) with stage I-III carcinoma stomach were included. Seventy-six percent patients underwent D2 lymphadenectomy; 12% received adjuvant chemotherapy alone while 88% received chemoradiotherapy. AT was initiated at a median 42 days after surgery; 17% started within 4 weeks, 55% between 4–8 weeks, and 28% after 8 weeks. Five-year RFS and OS for full cohort were 42.3±4.2% and 63.2±4.4%, respectively. On multivariate analysis, disease stage, ECOG performance status and time to AT emerged as significant predictors of RFS and OS while extent of lymphadenectomy, number of resected lymph nodes and margin positivity did not. Initiation of AT after 8 weeks was associated with significantly worse 5-year RFS (HR 2.28; 95% CI, 1.29–4.04; p=0.005) and OS (HR 2.65; 95% CI, 1.27–5.52; p=0.010).ConclusionsDelaying AT beyond 8 weeks after radical gastrectomy may be detrimental to disease recurrence and survival in patients with gastric cancer. If patients have adequately recovered, AT should preferably be initiated within 8 weeks of surgery.
- Published
- 2021
- Full Text
- View/download PDF
44. Identification and pathogenicity of Alternaria alternata causing leaf blight of Bacopa monnieri (L.) Wettst. and its biocontrol by Trichoderma species in agrifields--an ecofriendly approach
- Author
-
Swapan K. Ghosh, Sujoy Pal, and Subhankar Banerjee
- Subjects
Drug Discovery ,Plant Science - Published
- 2022
- Full Text
- View/download PDF
45. SELSI Consensus Statement for Safe Cholecystectomy—Prevention and Management of Bile Duct Injury—Part B
- Author
-
Lileswar Kaman, Virinder Kumar Bansal, Anil K. Agarwal, Ajay K. Khanna, Mahesh C. Misra, Kamal Kataria, Mohammad Aslam, Rajesh Bhojwani, JD Wig, Pramod Kumar Garg, Biju Pottakkat, Jaspal Singh, Muneer Khan, Anu Behari, Yashwant Singh Rathore, SD Maurya, Shaji Thomas, Bml Kapur, Om Prakash Prajapati, Sandeep Aggarwal, JB Agrawal, Nihar Ranjan Dash, Rajesh Gupta, Vinay K. Kapoor, Jagdish Chander, Chintamani, Subodh Kumar, Shivanand Gamangatti, KN Srivastava, Niyati M. Gupta, Rajeev Sinha, Peush Sahni, S. S. Sikora, Hemanga K. Bhattacharjee, Asuri Krishna, DP Singh, Amit Srivastava, Rajinder Parshad, Vijay K. Shukla, Anand Kumar, Rathindra Sarangi, Anurag Srivastava, Piyush Ranjan, Pawanindra Lal, P. N. Agarwal, Sujoy Pal, Pradeep Chowbey, Vuthaluru Seenu, Sandeep Kumar, SK Gupta, Tushar Kanti Chattopadhyay, Rajesh Khullar, Rajdeep Singh, IK Dhawan, Rajesh Panwar, GS Moirangthem, Atin Kumar, GR Verma, Abhay N Dalvi, Rajeev Sharma, Vikas Gupta, Aditya Baksi, and Shailesh Puntambekar
- Subjects
medicine.medical_specialty ,business.industry ,Bile duct ,General surgery ,Incidence (epidemiology) ,medicine.medical_treatment ,education ,Cardiac surgery ,03 medical and health sciences ,0302 clinical medicine ,medicine.anatomical_structure ,Cardiothoracic surgery ,030220 oncology & carcinogenesis ,Pediatric surgery ,medicine ,030211 gastroenterology & hepatology ,Surgery ,Cholecystectomy ,Neurosurgery ,Solo practice ,business - Abstract
Cholecystectomy is one of the commonest general surgical procedures performed all over India. The risk of bile duct injury (BDI) during laparoscopic cholecystectomy is two to three times higher than during open cholecystectomy. The worldwide incidence of bile duct injury is 0.5% or 1 in 200 cases. BDI and its consequences result in significant morbidity and may even cause mortality. BDI increases the cost of treatment and is a common reason for a medicolegal suit against the surgeons. To minimize the incidence of BDI and to manage it timely and appropriately, a set of guidelines was deemed necessary by a group of senior surgeons during a Society of Endoscopic and Laparoscopic Surgeons of India (SELSI) meeting in 2016. Guidelines for “Safe Laparoscopic Cholecystectomy” and bile duct injury management formulated by other international societies are already available. The applicability of these guidelines to Indian subjects especially in small peripheral centers was limited. Hence, a decision was taken to form a set of guidelines for general surgeons with basic laparoscopic skills with little or no advanced laparoscopic skills. Those working in a solo practice, nursing homes, and small private hospitals at talukas or districts should have “Safe Cholecystectomy” guidelines and management of BDI suitable to their situation. These guidelines were formed after three consensus meetings and have been approved by a SELSI Expert Group.
- Published
- 2019
- Full Text
- View/download PDF
46. SELSI Consensus Statement for Safe Cholecystectomy — Prevention and Management of Bile Duct Injury — Part A
- Author
-
Virinder Kumar Bansal, Mahesh C. Misra, Anil K Agarwal, JB Agrawal, PN Agarwal, Sandeep Aggarwal, Mohammad Aslam, Asuri Krishna, Aditya Baksi, Anu Behari, Hemanga K Bhattacharjee, Rajesh Bhojwani, Jagdish Chander, TK Chattopadhyay, null Chintamani, Pradeep Chowbey, Abhay Dalvi, NR Dash, IK Dhawan, Shivanand Gamangatti, PK Garg, NM Gupta, Rajesh Gupta, SK Gupta, Vikas Gupta, L Kaman, BML Kapur, Kamal Kataria, Muneer Khan, Ajay K Khanna, Rajesh Khullar, Anand Kumar, Atin Kumar, Sandeep Kumar, Subodh Kumar, Pawanindra Lal, SD Maurya, GS Moirangthem, Sujoy Pal, Rajesh Panwar, Rajinder Parshad, Biju Pottakkat, Om Prakash Prajapati, Shailesh Puntambekar, Piyush Ranjan, Yashwant Singh Rathore, Peush Sahni, Rathindra Sarangi, Vuthaluru Seenu, Rajeev Sharma, VK Shukla, DP Singh, Jaspal Singh, Rajdeep Singh, Rajeev Sinha, Sadiq S Sikora, Amit Srivastava, Anurag Srivastava, KN Srivastava, Shaji Thomas, GR Verma, JD Wig, and VK Kapoor
- Subjects
Surgery - Published
- 2019
- Full Text
- View/download PDF
47. Seaweed: An Alternative Liquid Fertilizer for Plant Growth
- Author
-
Dhananjay Tiwari, Satyendra Singh Gautam, Sujoy Pal, M. K. Singh, and Shikha Singh
- Subjects
Plant growth ,Agronomy ,Algae ,biology ,engineering ,Fertilizer ,engineering.material ,biology.organism_classification - Published
- 2019
- Full Text
- View/download PDF
48. Modified gemcitabine and oxaliplatin or gemcitabine + cisplatin in unresectable gallbladder cancer: Results of a phase III randomised controlled trial
- Author
-
Surya V. Deo, Ranjit Sahoo, Sunil Kumar, B. K. Mohanti, Atul Sharma, Sushmita Pathy, Sushma Bhatnagar, Sujoy Pal, Rakesh Kumar, Sanjay Thulkar, Surendra Pal Chaudhary, P. Sahni, Nootan Kumar Shukla, Dash Nr, Seema Mishra, Vinod Raina, Venkateswaran K. Iyer, and Vishnubhatla Sreenivas
- Subjects
Adult ,Male ,0301 basic medicine ,Cancer Research ,medicine.medical_specialty ,Adenocarcinoma ,Deoxycytidine ,Gastroenterology ,law.invention ,03 medical and health sciences ,0302 clinical medicine ,Randomized controlled trial ,law ,Internal medicine ,Antineoplastic Combined Chemotherapy Protocols ,Humans ,Medicine ,Cholecystectomy ,Gallbladder cancer ,Cisplatin ,Intention-to-treat analysis ,business.industry ,Middle Aged ,medicine.disease ,Gemcitabine ,Progression-Free Survival ,Confidence interval ,Intention to Treat Analysis ,Oxaliplatin ,Survival Rate ,Clinical trial ,Treatment Outcome ,030104 developmental biology ,Oncology ,030220 oncology & carcinogenesis ,Female ,Gallbladder Neoplasms ,business ,medicine.drug - Abstract
Aim To determine equivalence of modified gemcitabine and oxaliplatin compared with gemcitabine and cisplatin in unresectable gallbladder cancer (GBC). Primary end-point was overall survival (OS). Methods Open label, prospective, randomised phase III equivalence study. Inclusion criteria included histologically proven unresectable GBC, 18 years or older, adequate organ functions and Eastern Cooperative Oncology Group ≤2. Sample size 108 patients were required in each arm to have an equivalence margin of ±2 months with power of 80%. Treatment Modified gemcitabine and oxaliplatin (mGemOx)—gemcitabine 900 mg/m2, oxaliplatin 80 mg/m2, maximum 6 cycles; gemcitabine + cisplatin (CisGem)—gemcitabine 1000 mg/m2, cisplatin 25 mg/m2, maximum 8 cycles, all day 1 and 8 every 3 weeks. Results Two hundred sixty subjects were recruited between February 2011 and July 2015. Two hundred forty-three patients (119, mGemOx and 124, CisGem) received at least 1 dose and analysed for safety and efficacy (modified intention to treat). Median OS was 8·5 months for whole group (95% confidence interval [CI]: 7·9–9·1). Median OS in mGemOx was 9 months and 8·3 months in CisGem; p = 0·057 (hazard ratio = 0·78; 95% CI = 0·60-1·02). Restricted mean OS for follow-up limited to 30 months was 11·2 months (95% CI: 9·8–12·6) in mGemOx and 10·4 months (95% CI: 9·1–11·7) in CisGem. Difference of the mean was 0·8 months with 95% CI, exceeding 2 months (−1·1 to 2·7), hence rejecting equivalence. Peripheral neuropathy, thrombocytopaenia in mGemOx and nephrotoxicity was higher with CisGem. Conclusion This trial failed to show equivalence of eight cycles of CisGem to six cycles of mGemOx. Numerically OS was better with mGemOx. Toxicities were different. The trial was not powered to answer superiority. Clinical trial registration CTRI/2010/091/001406.
- Published
- 2019
- Full Text
- View/download PDF
49. Su1131: UNDERSTANDING THE MECHANISM OF SKELETAL MUSCLE WASTING IN CHRONIC PANCREATITIS
- Author
-
Neelam Lohani, Srikanth Gopi, Sumaira Qamar, Jatin Yegurla, Aman Chopra, Nidhi Singh, Uma Kanga, Namrata Singh, Nihar R. Dash, Sujoy Pal, Deepak Gunjan, and Anoop Saraya
- Subjects
Hepatology ,Gastroenterology - Published
- 2022
- Full Text
- View/download PDF
50. 1395P Impact of delay in adjuvant chemotherapy on survival in resected gastric cancer: Real world data from India
- Author
-
Arundhati Sharma, Sushmita Pathy, B. K. Mohanty, S. Kumar, S.V.S. Deo, N.R. Dash, N.K. Shukla, Vinod Raina, Sujoy Pal, S. Arora, and Raja Pramanik
- Subjects
Oncology ,medicine.medical_specialty ,Adjuvant chemotherapy ,business.industry ,Internal medicine ,medicine ,Cancer ,Hematology ,medicine.disease ,business ,Real world data - Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.